Shionogi initiates phase I trial in Japan of 3CL protease inhibitor S-217622 for COVID-19 July 26, 2021
Heterodimeric interference among IKZF family proteins results in inborn errors of immunity July 26, 2021
Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists July 26, 2021
RSS